4-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-anthracenyl)benzoic acid has been researched along with 4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid in 4 studies
| Studies (4-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-anthracenyl)benzoic acid) | Trials (4-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-anthracenyl)benzoic acid) | Recent Studies (post-2010) (4-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-anthracenyl)benzoic acid) | Studies (4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid) | Trials (4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid) | Recent Studies (post-2010) (4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid) |
|---|---|---|---|---|---|
| 14 | 0 | 0 | 174 | 2 | 29 |
| Protein | Taxonomy | 4-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-anthracenyl)benzoic acid (IC50) | 4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid (IC50) |
|---|---|---|---|
| Retinoic acid receptor alpha | Homo sapiens (human) | 0.036 | |
| Retinoic acid receptor beta | Homo sapiens (human) | 0.005 | |
| Retinoic acid receptor gamma | Homo sapiens (human) | 0.026 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 2 (50.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chao, WR; Dawson, MI; Derdzinski, KA; Frenking, G; Hobbs, PD; Jetten, AM; Loew, GH; Napoli, JL; Sani, BP; Williams, JB | 1 |
| Balaban, AT; Bonchev, D; Mountain, CF; Seitz, WA | 1 |
| Bernardon, JM; Charpentier, B; Eustache, J; Martin, B; Michel, S; Millois, C; Shroot, B | 1 |
| Balaguer, P; Lemaire, G; Michel, S; Rahmani, R | 1 |
4 other study(ies) available for 4-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-anthracenyl)benzoic acid and 4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid
| Article | Year |
|---|---|
Effect of structural modifications in the C7-C11 region of the retinoid skeleton on biological activity in a series of aromatic retinoids.
Topics: Animals; Cells, Cultured; Chemical Phenomena; Chemistry; Chick Embryo; Male; Molecular Conformation; Rabbits; Retinoids; Spectrophotometry, Ultraviolet; Structure-Activity Relationship | 1989 |
Modeling the anticarcinogenic action of retinoids by making use of the OASIS method. 3. Inhibition of the induction of ornithine decarboxylase by arotinoids.
Topics: Anticarcinogenic Agents; Models, Molecular; Molecular Conformation; Ornithine Decarboxylase; Ornithine Decarboxylase Inhibitors; Retinoids; Structure-Activity Relationship | 1994 |
Synthesis, structure-affinity relationships, and biological activities of ligands binding to retinoic acid receptor subtypes.
Topics: Animals; Cell Differentiation; Magnetic Resonance Spectroscopy; Mice; Receptors, Retinoic Acid; Recombinant Proteins; Retinoic Acid Receptor alpha; Retinoic Acid Receptor gamma; Retinoids; Structure-Activity Relationship; Teratocarcinoma; Tretinoin; Tumor Cells, Cultured | 1995 |
Activation of retinoic acid receptor-dependent transcription by organochlorine pesticides.
Topics: Animals; Benzoates; COS Cells; Cytochrome P-450 Enzyme System; Enzyme Induction; HeLa Cells; Humans; Hydrocarbons, Chlorinated; Insecticides; Naphthalenes; Receptors, Retinoic Acid; Retinoic Acid 4-Hydroxylase; Retinoids; Transcriptional Activation | 2005 |